TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
Clinical trials for TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA trials appear
Sign up with your email to follow new studies for TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to free aplastic anemia patients from transfusions
Disease control Not yet recruitingThis phase 2 trial tests a combination of three drugs—cyclosporine, a thrombopoietin receptor agonist (eltrombopag or hetrombopag), and romiplostim—in 43 adults newly diagnosed with severe aplastic anemia or transfusion-dependent non-severe aplastic anemia. The goal is to see if …
Matched conditions: TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for aplastic anemia: drug combo aims to cut transfusions
Disease control Not yet recruitingThis Phase 3 trial tests whether adding enarodustat to standard cyclosporine treatment helps people with transfusion-dependent non-severe aplastic anemia. The study will enroll 90 newly diagnosed adults who cannot have a stem cell transplant. The goal is to see if the combination…
Matched conditions: TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
Phase: PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC